Gene · 84634
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GPR54 regulates non-small cell lung cancer development via dopa decarboxylase. | Signal Transduct Target Ther | 2026 | 41771825 | PubTator, text mining | PubMed |
| Targeting the NR5A1-KISS1R-EMT axis with a small-molecule inhibitor suppresses lung adenocarcinoma progression and metastasis. | Cell Signal | 2026 | 41765312 | PubTator, text mining | PubMed |
| Differential microRNA Expression Profiles in Girls with Idiopathic Central Precocious Puberty and Premature Thelarche. | Int J Mol Sci | 2026 | 41751876 | PubTator, text mining | PubMed |
| Functional Validation of a Novel <italic>PBX1</italic> Missense Variant in a 46,XY Girl. | Sex Dev | 2026 | 41746858 | PubTator, text mining | PubMed |
| In vitro differentiation of the hypothalamic KNDy neuron, a master regulator for reproduction, from mouse embryonic stem cells. | Reprod Biol Endocrinol | 2026 | 41736118 | PubTator, text mining | PubMed |
| CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness. | Cell Death Dis | 2026 | 41714328 | PubTator, text mining | PubMed |
| Kallmann Syndrome in a 30-Year-Old Female With Primary Infertility: A Case Report. | Case Rep Obstet Gynecol | 2026 | 41709927 | PubTator, text mining | PubMed |
| Kisspeptin improves local ovarian insulin resistance in PCOS by modulating the PI3K/AKT/GLUT4 signaling pathway. | PLoS One | 2026 | 41628190 | PubTator, text mining | PubMed |
| Identification of a novel KISS1R (GPR54) gene variant (c.505+2T>G) in a patient with congenital hypogonadotropic hypogonadism: A case report and literature review. | Exp Ther Med | 2026 | 41623313 | PubTator, text mining | PubMed |
| Kisspeptins inhibit ectopic endometrial cell invasion and angiogenesis by suppressing PI3K/AKT signaling pathway via CREB5 in endometriosis. | Int J Med Sci | 2026 | 41399389 | PubTator, text mining | PubMed |
| Kisspeptin and early pregnancy: Insights from animal models into hormonal regulation and miscarriage. | J Neuroendocrinol | 2026 | 41310413 | PubTator, text mining | PubMed |
| Endometriosis - on the intersection of modern environmental pollutants and ancient genetic regulatory variants. | Eur J Hum Genet | 2026 | 41266756 | PubTator, text mining | PubMed |
| Expanded Targeted-Exome Sequencing and Functional Validation Improve Molecular Diagnosis and Refine Genotype-Phenotype Correlations in Congenital Hypogonadotropic Hypogonadism. | Neuroendocrinology | 2026 | 40924640 | PubTator, text mining | PubMed |
| Kisspeptin-54 ameliorates chondrocyte senescence in osteoarthritis via SIRT3-mediated telomere protection and p53 acetylation inhibition. | Neuropeptides | 2025 | 41022004 | PubTator, text mining | PubMed |
| REG3A promotes gemcitabine resistance in pancreatic cancer via the GPR54/ARRB2/ERK1/2 ligand-directed signaling pathway. | Biochem Pharmacol | 2025 | 40935160 | PubTator, text mining | PubMed |
| Genetic, neuropeptidergic, and cardiometabolic interplay in female central precocious puberty. | Cardiovasc Endocrinol Metab | 2025 | 40894469 | PubTator, text mining | PubMed |
| Kisspeptin Mitigates Hepatic De Novo Lipogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease. | Cells | 2025 | 40862768 | PubTator, text mining | PubMed |
| Drug repurposing in traditional Chinese medicine: from empirical wisdom to modern therapeutic strategies. | Front Pharmacol | 2025 | 40822477 | PubTator, text mining | PubMed |
| Metabolomic and Molecular Mechanisms of Glycerol Supplementation in Regulating the Reproductive Function of Kazakh Ewes in the Non-Breeding Season. | Animals (Basel) | 2025 | 40805081 | PubTator, text mining | PubMed |
| Comprehensive characterization of multi-omics landscapes between gut microbial metabolites and the druggable genome in sepsis. | Front Immunol | 2025 | 40761792 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84634/papers?page=2